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We report the case of a 46-year-old hypertensive Japanese female with renal insuﬃciency related to 
unilateral renal hypoplasia.  The patient was found to have developed paraganglioma in the retroperi-
toneal space over a 5-year period.  Catecholamine-producing tumors are not usually recognized as 
conditions associated with renal hypoplasia.  Our long-term observation of the patient eventually led us 
to the diagnosis of paraganglioma.  In hypertensive patients with chronic kidney disease,  not only the 
renin-angiotensin-aldosterone system but also catecholamine activity may be involved,  particularly in 
the patients whose cases are complicated with unilateral renal hypoplasia.
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e report the case of a hypertensive patient who 
developed paraganglioma in the retroperitoneal 
space of unilateral renal hypoplasia.  The co-existence 
of a catecholamine-producing tumor and unilateral renal 
hypoplasia is a very rare condition in the clinical set-
ting for hypertension.
Case Presentation
　 A 46-year-old Japanese female was referred to our 
hospital for the evaluation of hypertension with chronic 
kidney disease (CKD stage G3aA1; serum creatinine:  
0.84-0.90mg/dL,  eGFR: 54-60mL/min and no pro-
teinuria).  Her hypertension and tachycardia had been 
identiﬁed a few years earlier,  and she had been 
treated with a small dose of a β-blocker,  bisoprolol 
(2.5mg/day).  Her blood pressure on the ﬁrst visit was 
almost normal (109/80mmHg).  She had no abnormal 
ﬁndings regarding her neonatal period and no family 
history related to multiple endocrine neoplasia type 2 
(MEN2) including medullary thyroid carcinoma,  pheo-
chromocytoma or parathyroid hyperplasia,  though she 
had a surgical history for parotid cancer.
　 Abdominal computed tomography (CT) revealed 
that the right kidney was markedly smaller than the 
left kidney,  but no tumor lesion was detected in the 
retroperitoneal space (Fig.  1A).  The right kidney was 
morphologically small,  but the thickness of the renal 
cortex to the medullar area was proportional,  while 
the left kidney was marginally enlarged.
　 The initial endocrine examination showed normal 
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levels of serum aldosterone (11.2ng/dL; normal,  3.6-
24) and plasma renin activity (PRA; 1.1ng/mL/h;  
normal,  0.2-2.7).  At that time,  the patientʼs plasma 
levels of catecholamines were also within normal ranges 
(adrenaline: 0.03ng/mL,  normal,  ＜0.1; noradrenaline:  
0.39ng/mL,  normal,  0.1-0.5; and dopamine: 0.02ng/dL,  
normal,  ＜0.03).
　 To examine the diﬀerential function of bilateral 
kidneys,  we performed 99mTc-mercaptoacetyltriglycine 
renography,  and it showed functional loss of the right 
hypoplastic kidney with defects in the vascular phase 
in contrast to the preserved left side (Fig.  1B).  Based 
on the diagnosis of hypertension possibly related to her 
right renal ischemia regardless of normal levels of 
PRA,  the patientʼs renal function and blood pressure 
were occasionally re-examined.  Although a RAS 
inhibitor as a chronic kidney disease (CKD) treatment 
was administered once,  we discontinued it due to 
adverse eﬀects including tachycardia and general 
fatigue.  Her systolic blood pressure,  examined in our 
outpatient clinic over a period of a few years,  
increased slightly to 120-130mmHg,  though her renal 
function was not signiﬁcantly altered.
　 Five years after her referral to us,  she was admit-
ted to a neighboring hospital because of headache and 
moderate increase of blood pressure (130/84mmHg) 
under bisoprolol (3.75mg/day) treatment.  At that time,  
a screening abdominal CT incidentally uncovered a 
2.5-cm mass with early enhancement in the right retro-
peritoneal region (Fig.  1C).  Abdominal magnetic 
resonance imaging (MRI) exhibited a high-intensiﬁed 
tumor by T2-weighted images (Fig.  1D).  Fat-
suppression and spectral attenuated inversion recov-
ery (SPAIR) MRI further showed the least inclusion 
of adipose tissue in the tumor,  indicating that the 
tumor was likely to be a pheochromocytoma or para-
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Fig. 1　 A,  Right renal hypoplasia (arrowhead) shown by plain abdominal CT; B,  Functional defect of the right kidney shown by a 
renogram; C,  An enhanced retroperitoneal tumor (arrow) in the adrenal region shown by contrast-enhanced CT; D,  A high-intensiﬁed 
lesion (arrow) shown by T2-weighted MRI; E,  Accumulation of 123I-MIBG tracer (arrow) in the right adrenal region shown by SPECT; F,  
Gross feature of the resected tumor with adjacent normal adrenal; G,  Histological ﬁndings of the resected paraganglioma; H,  Hormonal 
changes in the clinical course.  Aldo,  aldosterone; NA,  noradrenaline; NSE,  neuron-speciﬁc enolase; PRA,  plasma renin activity.
ganglioma.
　 An endocrine examination conﬁrmed that the 
patientʼs plasma levels of catecholamines were increased 
compared to the levels 5 years earlier,  as follows:  
adrenaline,  0.02-0.05ng/mL,  noradrenaline,  4.25-
7.71ng/mL,  and dopamine,  0.02-0.07ng/mL (Fig.  
1H).  Urinary excretions of noradrenaline and its 
metabolites were also increased on admission as 
follows: adrenaline (7.9µg/day,  normal 3-41),  nora-
drenaline (900.9µg/day,  normal 31-160),  metaneph-
rine (0.07mg/day,  normal 0.04-0.18),  normetaneph-
rine (0.94mg/day,  normal 0.1-0.28),  and vanillyl 
mandelic acid (VMA; 10.1mg/day,  normal 1.5-4.3).
　 Laboratory data also showed that the patientʼs 
renal function (serum creatinine: 0.78-0.86mg/dL,  
eGFR 54.7-63.5mL/min,  and proteinuria: 60-100 
mg/day) was not signiﬁcantly changed compared with 
that 5 years before.  Of note,  her serum level of neu-
ron-speciﬁc enolase (NSE),  which was initially 
6.95ng/mL,  had increased to 21.5ng/mL (normal:
＜16.3) in 5 years (Fig.  1H).  In addition,  the levels 
of plasma adrenocorticotropin (ACTH; 18.3pg/mL,  
normal 7.2-63.3),  cortisol (14.6µg/dL,  normal 8-25),  
aldosterone (19.9ng/dL) and PRA (1.5ng/mL/h) 
were within normal ranges.
　 Single photon emission CT (SPECT) using 
123I-metaiodobenzylguanidine (MIBG) exhibited a spe-
ciﬁc spot in the right peritoneal lesion (Fig.  1E),  
leading to the diagnosis of a catecholamine-producing 
tumor in the right adrenal region.  Laparoscopic 
resection of the tumor was performed after careful 
preconditioning with oral doxazosin (6mg/day) and 
daily transfusion (Fig.  1H).  The adjunct right hyp-
oplastic kidney and adrenal gland were also removed 
en bloc due to tissue adhesion.
　 The resected tumor was proven to be paragan-
glioma pathologically separated from the normal 
adrenal and partly adhered to the right renal capsule 
(Fig.  1F).  The pathological workup showed that the 
paraganglioma was benign,  with 2 points on the 
PASS (Pheochromocytoma of the Adrenal Gland 
Scaled Score) consisting of capsular invasion and 
profound nuclear pleomorphism [1] (Fig.  1G).  Renal 
pathology also revealed that the resected kidney had a 
hypoplastic feature but no atrophic change,  based on 
the reduced number of normal glomeruli in the 
resected renal specimens.  After the surgery,  no 
antihypertensive drug was needed and the patientʼs 
renal function was nearly preserved (eGFR of 
50-60mL/min).
Discussion
　 Catecholamine-producing tumors such as pheochro-
mocytomas and paragangliomas are not clinically rec-
ognized as conditions associated with renal hypoplasia.  
However,  the occurrence of a pheochromocytoma in 
patients complicated with renal agenesis or hypoplasia 
has occasionally been reported [2,  3].  The genes 
RET,  VHL,  NF1 and SDH are known to be related to 
the development of pheochromocytomas and paragan-
gliomas [4-6].  Renal malformation and/or agenesis is 
likely to be linked to the RET mutation that is associ-
ated with MEN2 including pheochromocytomas.  The 
RET gene seems to be functionally involved in the 
embryonic process of renal formation and renal devel-
opment in mammals [7,  8].
　 Although the RET oncogene mutation was not 
examined in our patient because of the lack of a sig-
niﬁcant family history,  we cannot completely exclude 
the possibility of occult RET mutation in our patient 
in light of her history of parotid cancer and the 5ｵ 
rate of sporadic MEN2 patients [8].  In another case,  
renal arterial stenosis secondarily caused by a cate-
cholamine-producing tumor was reported [9].  In that 
patient,  the ipsilateral renal feeding artery was com-
pressed by the adjacent enlarged tumor [9],  unlike 
our patientʼs hypoplastic kidney.
　 In the present case,  the ﬁrst hospital visit was due 
to mild hypertension and CKD complicated with uni-
lateral renal hypoplasia.  However,  long-term observa-
tion eventually led us to the diagnosis of a cate-
cholamine-producing tumor (Fig.  1H).  In our patient,  
a RET gene analysis was not performed because we 
could not obtain the patientʼs permission.  In any case,  
careful follow-up is needed in the future due to the 
risk of recurrence and/or occurrence of MEN2-
related lesions.  Physicians sometimes come across 
hypertensive patients with an atrophic unilateral kid-
ney.  In such cases,  the patientʼs renin-angiotensin-
aldosterone system (RAS) should be evaluated ﬁrst in 
order to exclude the possibility of renovascular hyper-
tension.  The pathophysiologic relationship between 
renal hypoplasia and paraganglioma remains unclear.  
However,  it would be clinically important to check 
catecholamine levels as well in hypertensive patients 
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to rule out the existence of catecholamine-producing 
tumors,  particularly in patients complicated with 
unilateral renal hypoplasia.
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